CRT 2026
Coronary
Carlo Di Mario, MD
Professor
University of Florence
Florence, Toscana, Italy
Disclosure(s): Amgen: Grant/Research Support (Terminated, July 1, 2024); BSC: Grant/Research Support (Ongoing); Novo Nordisk: Grant/Research Support (Ongoing)
Allison B. Hall, MD, FRCPC
Interventional Cardiologist, Clinical Assistant Professor of Medicine
NL Health Services/Memorial University of Newfoundland
St. John's, Newfoundland and Labrador, Canada
Disclosure information not submitted.
Stephane Rinfret, MD, SM
Director of Complex Coronary Interventions
Georgia Heart Institute
Gainesville, Georgia, United States
Disclosure information not submitted.
Brian Bergmark, MD
Interventional Cardiologist, Complex Coronary and CTO Program
Brigham and Women's Hospital, Harvard Medical School
Disclosure information not submitted.
Lindsey Cilia, MD
Co-Director of Complex Coronary Therapeutics Program
Interventional Cardiologist
Inova Heart and Vascular Institute/Virginia Heart
Falls Church, Virginia, United States
Disclosure(s): No financial relationships to disclose
Jeffrey W. Moses, MD, FSCAI
John and Myrna Daniels Professor of Cardiology
Columbia University Medical Center
New York, New York, United States
Disclosure information not submitted.
Debabrata Dash, MD, DM, FICC, FSCAI, FAPHA, , FACC, FESC
Consultant Interventional Cardiologist
Aster Hospital, Al Mankhool Dubai, UAE
Dubai, Dubai, United Arab Emirates
Disclosure(s): No financial relationships to disclose
Angela M. Taylor, MD, MS, MBA
Professor
University of Virginia
Charlottesville, Virginia, United States
Disclosure information not submitted.
Seung-Woon Rha, MD, PhD, FACC
Professor
Korea University Guro Hospital
Seoul, Republic of Korea
Disclosure(s): No financial relationships to disclose
Masahisa Yamane, MD
Senior Advisor
Saitama Sekishinkai Hospital
Tokyo, Tokyo, Japan
Disclosure(s): Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)